Eltoukhy Helmy 4

What Happened

• Helmy Eltoukhy, CEO of Guardant Health, had restricted stock units (RSUs) convert into common shares at no exercise price and the company withheld shares to cover tax withholding. Across March 31 and April 1, 2026, 36,530 shares were issued on conversion and 18,515 shares were surrendered/withheld for taxes, valued at $1,689,384 (1,428 shares @ $92.37 = $131,904; 17,087 shares @ $91.15 = $1,557,480). The transactions reflect RSU vesting and a cashless settlement for tax obligations rather than an open-market sale.

Key Details

• Transaction dates and values:
  • 2026-03-31: 2,817 RSU conversions (acquired) and 1,428 shares withheld @ $92.37 (disposed) = $131,904.
  • 2026-04-01: 23,997 and 9,716 RSU conversions (acquired) and 17,087 shares withheld @ $91.15 (disposed) = $1,557,480.
  • Total converted: 36,530 shares. Total withheld/disposed for taxes: 18,515 shares for $1,689,384.
• Net newly issued to insider: 36,530 converted − 18,515 withheld = 18,015 shares retained by the insider (filing does not state total shares owned after the transactions).
• Footnotes:
  • F1: Company retained shares to meet the award-holder’s tax withholding; retention not in excess of tax liability.
  • F2/F4/F5: The converted shares came from multiple RSU grants (including a March 17, 2026 grant that vests in quarterly installments and earlier multi-year grants with staged vesting).
  • F3: Not applicable for RSUs.
• Timeliness: Report filed 2026-04-02 for report period ending 2026-03-31; filing does not indicate lateness.

Context

• These transactions are transitions of RSUs into common stock with a cashless tax-withholding settlement (company retained shares to pay taxes). That is routine for executives receiving RSU vesting and does not necessarily signal a buy/sell opinion by the insider.
• For retail investors: purchases or open-market buys can be more informative as a bullish signal; here the activity reflects compensation vesting and standard tax withholding.